Skip to main content
TipRanks
Go Ultimate75% OFF

Picard Medical, Inc. (PMI) Ratios

91 Followers

Picard Medical, Inc. Ratios

PMI's free cash flow for Q2 2026 was $-1.35M. For the 2026 fiscal year, PMI's free cash flow was increased by $0.00 and operating cash flow was $-1.35M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio1.110.280.954.04
Quick Ratio0.720.050.201.60
Cash Ratio0.400.000.030.05
Solvency Ratio-1.41-0.57-1.00-2.61
Operating Cash Flow Ratio-0.84-0.34-1.15-3.58
Short-Term Operating Cash Flow Coverage-2.43-0.59-2.62-17.30
Net Current Asset Value$ 1.97M$ -26.05M$ -6.17M$ 8.05M
Leverage Ratios
Debt-to-Assets Ratio0.311.730.830.13
Debt-to-Equity Ratio1.84-0.88-2.650.17
Debt-to-Capital Ratio0.65-7.451.610.15
Long-Term Debt-to-Capital Ratio0.000.005.870.00
Financial Leverage Ratio5.95-0.51-3.201.36
Debt Service Coverage Ratio-4.11-0.76-3.54-16.99
Interest Coverage Ratio0.00-4.47-110.73-2213.40
Debt to Market Cap0.050.060.030.00
Interest Debt Per Share4.730.330.130.03
Net Debt to EBITDA0.02-1.19-0.62-0.17
Profitability Margins
Gross Profit Margin4.05%-2.55%-45.83%-121.27%
EBIT Margin-546.56%-410.00%-305.99%-271.14%
EBITDA Margin-536.19%-397.63%-294.39%-257.89%
Operating Profit Margin-259.11%-312.28%-307.40%-269.07%
Pretax Profit Margin-546.56%-479.85%-308.76%-271.26%
Net Profit Margin-546.56%-479.50%-308.72%-271.53%
Continuous Operations Profit Margin-546.56%-479.50%-308.72%-271.53%
Net Income Per EBT100.00%99.93%99.99%100.10%
EBT Per EBIT210.94%153.66%100.45%100.81%
Return on Assets (ROA)-119.74%-173.92%-136.88%-72.33%
Return on Equity (ROE)-712.59%88.70%438.32%-98.23%
Return on Capital Employed (ROCE)-332.21%59.06%-717.02%-88.96%
Return on Invested Capital (ROIC)-118.91%487.80%-237.40%-83.04%
Return on Tangible Assets-126.03%-193.25%-154.53%-79.46%
Earnings Yield-20.93%-6.37%-4.71%-3.38%
Efficiency Ratios
Receivables Turnover6.537.036.811.13
Payables Turnover2.280.852.396.54
Inventory Turnover0.650.551.071.24
Fixed Asset Turnover7.083.983.842.13
Asset Turnover0.220.360.440.27
Working Capital Turnover Ratio-0.42-0.341.160.00
Cash Conversion Cycle458.20280.70242.73561.19
Days of Sales Outstanding55.9351.9553.63323.20
Days of Inventory Outstanding562.36657.78342.12293.81
Days of Payables Outstanding160.09429.04153.0255.83
Operating Cycle618.29709.73395.75617.01
Cash Flow Ratios
Operating Cash Flow Per Share-10.63-0.16-0.15-0.15
Free Cash Flow Per Share-10.63-0.16-0.15-0.15
Dividend Paid and CapEx Coverage Ratio0.000.00-1519.14-369.76
Capital Expenditure Coverage Ratio0.000.00-1519.14-369.76
Operating Cash Flow Coverage Ratio-2.25-0.57-1.13-5.47
Operating Cash Flow to Sales Ratio-3.17-2.70-2.11-2.61
Free Cash Flow Yield-12.15%-3.59%-3.22%-3.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-4.73-13.91-21.24-29.61
Price-to-Sales (P/S) Ratio26.1175.3265.5880.41
Price-to-Book (P/B) Ratio34.04-13.93-93.1129.09
Price-to-Free Cash Flow (P/FCF) Ratio-8.23-27.85-31.08-30.76
Price-to-Operating Cash Flow Ratio-8.23-27.85-31.10-30.84
Price-to-Earnings Growth (PEG) Ratio-0.39-0.43-0.550.00
Enterprise Value Multiple-4.85-20.14-22.90-31.35
Enterprise Value128.52M351.57M339.90M332.54M
EV to EBITDA-4.85-20.14-22.90-31.35
EV to Sales26.0280.0767.4080.85
EV to Free Cash Flow-8.20-29.61-31.94-30.93
EV to Operating Cash Flow-8.20-29.61-31.96-31.01
Tangible Book Value Per Share1.81-0.35-0.070.14
Shareholders’ Equity Per Share2.57-0.33-0.050.16
Tax and Other Ratios
Effective Tax Rate0.000.000.00-0.00
Revenue Per Share3.350.060.070.06
Net Income Per Share-18.32-0.29-0.22-0.15
Tax Burden1.001.001.001.00
Interest Burden1.001.171.011.00
Research & Development to Revenue0.610.770.440.46
SG&A to Revenue2.022.330.000.00
Stock-Based Compensation to Revenue0.150.200.030.04
Income Quality0.580.560.680.96

Currency in USD